News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

IVAX Corporation (IVX) And Grupo Ferrer Internacional S.A. To Collaborate On Late-Stage Drug For Acute Stroke


10/19/2005 5:11:54 PM

IVAX Corporation (AMEX:IVX)(LSE:IVX.L) announced today that it has entered into a licensing agreement with Grupo Ferrer, an international pharmaceutical company headquartered in Barcelona, Spain, for the final development of citicoline, an oral neuroprotective therapy for the treatment of stroke.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES